You are here: Industry Insights > Glenmark

News List

Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19 expresspharma
November 25, 2020
These findings were observed in Phase 3 clinical trial conducted by Glenmark Pharmaceuticals and have been published by the International Journal of Infectious Diseases.
Glenmark Pharma gets ANDA approval for Tacrolimus Capsules expresspharma
November 12, 2020
It is the generic version of Prograf Capsules of Astellas Pharm.
Glenmark Pharma receives USFDA approval for Sirolimus tablets expresspharma
October 21, 2020
These tablets are the generic version of Rapamune Tablets, 0.5 mg, 1 mg and 2 mg, of PF Prism CV.
SEC asks CDSCO to submit adverse event report of death during Umifenovir trial expresspharma
October 16, 2020
The Subject Expert Committee (SEC) has asked CDSCO to submit data of the reported serious adverse event (SAE), a single death, from the clinical trials of the drug combination of Favipiravir + Umifenovir by Glenmark Pharmaceuticals.
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India expresspharma
October 16, 2020
Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced pulmonary fibrosis in moderate to severe COVID-19 patients.
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study expresspharma
October 10, 2020
The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India.
Glenmark Pharmaceuticals gets ANDA approval for multiple sclerosis drug expresspharma
October 10, 2020
Glenmark’s current portfolio consists of 164 products authorised for distribution in the US marketplace and 46 ANDA’s pending approval with the US FDA.
Teva Charged in Ongoing Criminal Antitrust Investigation americanpharmaceuticalreview
September 07, 2020
Teva Pharmaceuticals USA has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice announced.
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors expresspharma
August 18, 2020
Bhattacharjee was previously President & CEO – Global Generic Medicines of Teva Pharmaceutical Industries.
Glenmark to launch FabiFlu (400 mg) for COVID-19 treatment expresspharma
August 07, 2020
With the new 400 mg version, patients need to consume nine tablets on Day 1, and thereafter two tablets twice a day from Day 2 till the end of the course.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page